AEMD

NASDAQ 已收盘

Aethlon Medical

5.46 USD
▲+0.62+12.81%
盘后 5.50 +0.73%
2026-11-20
市值
$8.78M
市盈率
—
EPS
-17.80
股息率
—
52 周区间
1.41 – 24.75
成交量
211.84K
Beta
1.23
目标价
13.25
52W 低 1.4152W 高 24.75
价格走势

公司简介

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.